Total Payments
$52,991
2024 Payments
$1,879
Companies
63
Transactions
554
Medicare Patients
12,132
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$38,959 (73.5%)
Food & Beverage$8,900 (16.8%)
Travel$4,803 (9.1%)
Education$328.74 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,784 | 25 | 73.2% |
| Food and Beverage | $8,900 | 494 | 16.8% |
| Travel and Lodging | $4,803 | 28 | 9.1% |
| Education | $328.74 | 6 | 0.6% |
| Honoraria | $175.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $39,670 | 140 | $0 (2024) |
| Grifols USA, LLC | $4,231 | 18 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $1,294 | 7 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,216 | 30 | $0 (2024) |
| ModernaTX, Inc. | $1,214 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $714.80 | 42 | $0 (2024) |
| ABBVIE INC. | $610.52 | 66 | $0 (2024) |
| PFIZER INC. | $347.59 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $311.81 | 23 | $0 (2022) |
| Lilly USA, LLC | $252.57 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,879 | 51 | ModernaTX, Inc. ($1,214) |
| 2023 | $1,677 | 65 | Bayer Healthcare Pharmaceuticals Inc. ($812.47) |
| 2022 | $2,677 | 99 | Alnylam Pharmaceuticals Inc. ($1,294) |
| 2021 | $1,341 | 88 | SANOFI PASTEUR INC. ($194.88) |
| 2020 | $966.32 | 59 | Boehringer Ingelheim Pharmaceuticals, Inc. ($150.39) |
| 2019 | $13,410 | 61 | Janssen Pharmaceuticals, Inc ($13,078) |
| 2018 | $11,597 | 60 | Janssen Pharmaceuticals, Inc ($11,353) |
| 2017 | $19,443 | 71 | Janssen Pharmaceuticals, Inc ($15,009) |
All Payment Transactions
554 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: Cardio-renal | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardio-renal | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: Cardio-renal | ||||||
| 10/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $45.48 | General |
| Category: Vaccines | ||||||
| 10/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardio-renal | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: PAIN | ||||||
| 09/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Cardio-renal | ||||||
| 08/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| 08/12/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Neuropsychiatry | ||||||
| 07/19/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 07/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/15/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Pulmonology | ||||||
| 07/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,049 | 3,946 | $431,211 | $192,870 |
| 2022 | 43 | 2,478 | 5,648 | $658,897 | $330,931 |
| 2021 | 50 | 3,376 | 7,043 | $815,369 | $436,844 |
| 2020 | 53 | 4,229 | 7,717 | $807,026 | $419,333 |
Total Patients
12,132
Total Services
24,354
Medicare Billing
$1.4M
Procedure Codes
183
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 554 | $83,100 | $46,571 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 242 | 545 | $54,500 | $31,731 | 58.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 213 | 213 | $31,950 | $25,434 | 79.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 118 | 299 | $22,425 | $13,482 | 60.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 57 | 143 | $39,910 | $11,290 | 28.3% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 47 | 93 | $13,950 | $9,044 | 64.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 306 | 648 | $8,440 | $5,443 | 64.5% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 32 | 100 | $10,000 | $5,161 | 51.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 72 | 143 | $11,440 | $4,944 | 43.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 48 | $24,050 | $4,608 | 19.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 40 | 40 | $16,677 | $3,992 | 23.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 26 | $19,136 | $3,433 | 17.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 79 | 92 | $9,200 | $3,285 | 35.7% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 48 | 49 | $13,171 | $2,927 | 22.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 42 | $11,130 | $2,534 | 22.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 35 | 48 | $7,195 | $2,521 | 35.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 39 | 41 | $10,906 | $2,495 | 22.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,275 | $1,997 | 87.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 47 | 210 | $6,090 | $1,775 | 29.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 60 | 134 | $6,700 | $1,655 | 24.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 11 | 11 | $2,362 | $1,502 | 63.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 16 | $6,064 | $1,436 | 23.7% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 11 | 14 | $2,100 | $1,339 | 63.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 12 | $1,200 | $798.48 | 66.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,925 | $743.49 | 38.6% |
About Dr. Brian Smith, MD
Dr. Brian Smith, MD is a Emergency Medicine healthcare provider based in Versailles, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992749873.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Smith, MD has received a total of $52,991 in payments from pharmaceutical and medical device companies, with $1,879 received in 2024. These payments were reported across 554 transactions from 63 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,784).
As a Medicare-enrolled provider, Smith has provided services to 12,132 Medicare beneficiaries, totaling 24,354 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Versailles, KY
- Active Since 06/15/2006
- Last Updated 06/09/2022
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1992749873
Products in Payments
- INVOKANA (Drug) $38,891
- Prolastin-C (Biological) $4,059
- Kerendia (Drug) $1,216
- XARELTO (Drug) $570.45
- VRAYLAR (Drug) $378.27
- JARDIANCE (Drug) $353.71
- TRELEGY ELLIPTA (Drug) $271.14
- SPRAVATO (Drug) $207.62
- UBRELVY (Drug) $174.43
- Prolastin-C Liquid (Biological) $172.18
- ELIQUIS (Drug) $163.46
- ENTRESTO (Drug) $159.59
- TRULICITY (Drug) $135.71
- AJOVY (Drug) $134.43
- AZSTARYS (Drug) $117.59
- MOUNJARO (Drug) $116.86
- Azstarys (Drug) $114.96
- STIOLTO RESPIMAT (Drug) $114.89
- REXULTI (Drug) $113.24
- Auvelity (Drug) $112.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.